There were 1,498 press releases posted in the last 24 hours and 355,292 in the last 365 days.

Annual General Meeting and Interim Management Statement

This Interim Management Statement covers the period from 1 April 2011 to 30 June 2011, which is the first quarter of the financial year. At the Annual General Meeting of Tate & Lyle PLC, to be held in London today, Sir Peter Gershon, Chairman, will make the following statement:

INTERIM MANAGEMENT STATEMENT

OPERATING PERFORMANCE – CONTINUING OPERATIONS

The Group has made an encouraging start to the financial year, with a solid operational performance assisted by strong co-product returns, which were partially offset by the impact of currency movements on the translation of profits.

In our Speciality Food Ingredients division, overall volumes grew over the first quarter of the previous financial year, driven by solid demand for our corn-based speciality sweeteners and SPLENDA® Sucralose. Our plans to re-open the SPLENDA® Sucralose facility in McIntosh, Alabama are proceeding in line with expectations. In Food Systems we saw a continuation of tough trading conditions, particularly in Russia, and expect these to continue for the remainder of the year.

Within Bulk Ingredients, demand for liquid sweeteners remained firm in both the Americas and in Europe. In Europe, as anticipated, starch margins benefited from increased prices for industrial starches, although they were largely offset by sweetener margins which were lower because of higher raw material costs. Citric acid sales were lower than expected in a more competitive market, which we expect to continue for the remainder of the year.

In the first quarter, co-product returns benefited from higher market prices and we locked in sales further forward than usual to take advantage of strong demand. We still anticipate more normal co-product returns for the remainder of the year, especially when compared with the strong co-product performance in the second half of last financial year. Movements in co-products primarily affect the Bulk Ingredients division.

DEBT MANAGEMENT AND BALANCE SHEET

The Group’s financial position has continued to strengthen.

Net debt of £454 million at 30 June 2011 has reduced from £464 million at 31 March 2010. The impact of exchange translation on reported net debt in the quarter was negligible. During June, at their maturity, we redeemed the US$300 million bonds from our own funds.

The triennial valuation of the main UK pension scheme as at 31 March 2010 was concluded with a funding deficit of £88 million. Following the sale of the main UK sugar and molasses assets in the last financial year, we will pay £45 million cash into the scheme in the year ending 31 March 2012. The balance of the deficit will be paid at an annual rate of £12 million thereafter.

Following the quarter end, we concluded the refinancing of the Group’s US$1 billion revolving credit facility with a new, US$800 million five year committed revolving credit facility.

On July 15, Standard & Poor's upgraded Tate & Lyle’s credit rating to “BBB/A-2 (stable outlook)” from “BBB-/A-3 (stable outlook)”.

G.C.HAHN & CO

In June, the former owner of G.C. Hahn & Co, which makes up the majority of our Food Systems operations in Europe, exercised their option to sell their remaining 5% shareholding to Tate & Lyle for a total cost of €8 million. As a result, Tate & Lyle now owns 100% of this company.

OUTLOOK

We expect the current demand patterns for our main products in both Speciality Ingredients and Bulk Ingredients to continue. As planned, we are starting to diversify some US grind from Bulk Ingredients to Speciality Food Ingredients. Bulk sweetener volumes in the US are therefore expected to be slightly lower for the full year.

Overall, our expectations for the full year remain unchanged and we continue to anticipate another year of profitable growth.

END

A conference call will be held today at 7:30am BST, hosted by Javed Ahmed, Chief Executive and Tim Lodge, Chief Financial Officer. Participants are requested to dial in at least 5 minutes before the commencement of the call. Dial in details are as follows:

Participant dial in number: +44 (0) 1452 555 566

Conference ID: 83482849

Replay dial in number: +44 (0) 1452 55 00 00

Replay passcode: 83482849#

A replay of this call will be available from two hours after the end of the live call for 7 days until 3 August 2011.

For more information contact Tate & Lyle PLC:

Mathew Wootton, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7977 6211 or Mobile: +44 (0) 7500 100 320

Andrew Lorenz (Financial Dynamics), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807


 

For more information contact:
Archi Quddus
Tate & Lyle
t:+442079776302
e: archi.quddus@tateandlyle.com
 
Mathew Wootton
Tate & Lyle PLC
t:+44 (0)20 7977 6211
m:+44 (0)7500 100 320
e: mathew.wootton@tateandlyle.com
 

About Tate & Lyle:   

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.

Tate & Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.

Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches and sweeteners), SPLENDA® Sucralose (a high intensity sweetener made from sugar) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
 
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2011, Tate & Lyle sales totalled £2.7 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC

 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.